Living, Breathing Logistics
The supply of cell and gene therapies is a delicate operation – and easily broken, just like daisy chains.
With CAR-Ts approved in both the US and the EU, the advanced therapies field is answering the scientific questions of efficacy and safety – cell and gene therapies are becoming therapeutic realities. But new challenges are emerging...
How can manufacturing become more closed and automated to reduce the risks associated with human intervention and manual operations? How does the field overcome the problem of handling living breathing cells in transit? And are healthcare systems ready for cell and gene therapies?
Enjoy our FREE content!
Log in or register to read this article in full and gain access to The Medicine Maker’s entire content archive. It’s FREE and always will be!
Login if you already created an account
Or register now - it’s free and always will be!
You will benefit from:
- Unlimited access to ALL articles
- News, interviews & opinions from leading industry experts
- Receive print (and PDF) copies of The Medicine Maker magazine